Complement Receptor 1 (CR1) Expression in Chronic Myeloid Leukemia

References

• Fearon D. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proceeding of the National Academy of Sciences of the United States of America 1979; 76: 5867–71
   PubMed Web of Science ®Google Scholar
• McMichael A. J. Leukocyte typing III. White cell differentiation antigens. Oxford University Press, Oxford 1987; 590–1, CD35 (group 6)
   Google Scholar
• Calligaris Cappio R., Schena M., Bergui L., Tesio L., Riva M., Rege-Cambrin G., Funaro A., Malavasi F. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes. Leukemia 1987; 1: 746–52
   PubMed Web of Science ®Google Scholar
• Lambris J. D. The multifunctional role of C3, the third component of complement. Immunology Today 1988; 12: 387–93
   Google Scholar
• Malavasi F., Kazatchkine M., Riva M., Calligaris Cappio F., Coppo R., . Report on the CD35 cluster workshop. Leukocyte Typing IV, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E.H. Schmidt, E. G. von dem Borne Stein, et al. Oxford University Press, Oxford 1990; 831–4
   Google Scholar
• Lanza Fagioli F. F., Gavioli R., Spisani S., Malavasi F., Castoldi G. L., Traniello S. Evaluation of CR1 expression in neutrophils from chronic myeloid leukemia: relationship between prognosis and cellular activity. British Journal of Haematology 1991; 77: 66–72
   PubMed Web of Science ®Google Scholar
• Kinoshita T. Biology of complement: the overture. Immunology Today 1991; 12: 291–5
   PubMedGoogle Scholar
• Dikman T., Hatch J., Atkinson J. Polimorphism of the human C3b/C4b receptor. Journal of Experimental Medicine 1984; 159: 691–703
   PubMed Web of Science ®Google Scholar
• Bettelheim P. Cluster report: CD35. Leukocyte Typing IV, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E.H. Schmidt, E. G. Stein von dem Borne. Oxford University Press, Oxford 1990; 829–30
   Google Scholar
• Welcht R., Beishel L., Kleesattel A. Functional consequences of the genetic polymorphism of the third component of complement. Journal of Pediatrics 1990; 116: 592–7
   PubMed Web of Science ®Google Scholar
• Tausk F., Gigli I. The human C3b receptor: function and role in human diseases. Journal of Investigative Dermatology 1990; 94: 141S–3S
   PubMed Web of Science ®Google Scholar
• Wong W. W. Structural and functional correlation of the human complement receptor type 1. Journal of Investigative Dermatology 1990; 94: 64S–7S
   PubMed Web of Science ®Google Scholar
• Lowell C. A., Klickstein L. B., Carter R. H., Mithcell J. A., Fearon D. T., Ahearn J. M. Mapping of the Epstein Barr virus and C3dg binding sites to a common domain on complement receptor type 2. Journal of Experimental Medicine 1989; 170: 1931–46
   PubMed Web of Science ®Google Scholar
• Holguin M. H., Kurtz C. B., Parker C. J., Weis J. J., Weis J. H. Loss of human CR1 and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. Journal of Immunology 1990; 145: 1776–81
   PubMed Web of Science ®Google Scholar
• Patrone F., Dallegri F., Bonvini E., Frumento G., Nocera Ferrarini A. M., Sacchetti C. Modulation of neutrophil Fc and C3b receptors. Inflammation 1983; 7: 155–68
   PubMed Web of Science ®Google Scholar
• O'Shea J. J., Brown E. J., Seligmann B. E., Metcalf J. A., Frank M. M., Gallin J. I. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. The Journal of Immunology 1985; 134: 2580–7
   PubMed Web of Science ®Google Scholar
• Ogle J. D., Ogle K., Noel G., Solomkin J. S., Alexander J. M. Determination of C3b receptors. On normal and patient polymorphonuclear neutrophils with C3b-coated fluorescent microspheres. Archives of Surgery 1985; 120: 104–9
   PubMed Web of Science ®Google Scholar
• Malech H. L., Gallin J. I. Neutrophils in human diseases. The New England Journal of Medicine 1987; 11: 687–94
   Web of Science ®Google Scholar
• Malbram A., Sivik S., Frank M. M., Fries L. M. CR1-receptor recyling in phorbol ester-activated polymorphonuclear leukocytes. Immunology 1988; 63: 325–30
   PubMed Web of Science ®Google Scholar
• Hemler M. E. Adhesive protein receptors on hematopoietic cells. Immunology Today 1988; 12: 109–13
   Google Scholar
• Castoldi G. L., Lanza F. Fisiologia e alterazioni dei leucociti. patologia Medica, edited by “Autori Vari”. Piccin Publishing, Padova 1989; 265–95
   Google Scholar
• Porteu F., Mir A., Mecarelli L. H. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomelic human C3b. European Journal of Immunology 1987; 17: 629–35
   PubMed Web of Science ®Google Scholar
• Van-Epps D. E., Bender J. G., Simpson S. J., Chenoweth D. E. Relationship of chemotactic receptors for formyl peptide and C5a to CR1, CR3, and Fc receptors on human neutrophils. Journal of Leukocyte Biology 1990; 47: 519–27
   PubMed Web of Science ®Google Scholar
• Ogle J. D., Noel J. G., Sramkoski R. M., Ogle C. K., Alexander J. W. Effects of chemotactic peptide f-Met-Leu-Phe (FMLP) on C3b receptor (CR1) expression and phagocytosis of microspheres by human neutrophils. Inflammation 1990; 14: 337–53
   PubMed Web of Science ®Google Scholar
• Ogle J. D., Noel J. G. Comparison of abilities of recombinant interleukin 1 alpha and beta and non inflammatory IL1 beta fragment 163–171 to upregulate C3b receptors (CR1) on human neutrophils and to enhance their phagocytic capacity. Inflammation 1990; 14: 185–94
   PubMed Web of Science ®Google Scholar
• Paccaud J. P., Schifferli J. A., Baggiolini M. NAP-l/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. Biochemical and Biophysical Research Community 1990; 166: 187–92
   PubMed Web of Science ®Google Scholar
• Lachman P. The control of homologous lysis. Immunology Today 1991; 12: 312–5
   PubMedGoogle Scholar
• Kazatchkine M., Fearon D. T. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodeficiency Reviews 1990; 2: 17–41
   PubMedGoogle Scholar
• Fearon D. T., Klickstein L. B., Wong W. W., Wilson J. G., Moore F. D., Weis J. J., Weis J. H., Jack R. M., Carter R. H., Ahern J. A. Immunoregulatory functions of complement receptor type 1 (CR1; CD35) and type 2 (CR2: CD21). Progress in Clinical and Biological Research 1989; 297: 211–20
   PubMedGoogle Scholar
• Frank M., Fries L. The role of complement in inflammation and phagocytosis. Immunology Today 1991; 12: 322–6
   PubMedGoogle Scholar
• Andoh A., Fujiyama Y., Kitoh K., Hodohara K., Bamba T., Hosoda S. Flow cytometric assay for phagocytosis of human monocytes mediated via Fcg receptors and complement receptor CR1 (CD35). Cytometry 1991; 12: 677–86
   PubMedGoogle Scholar
• Gerdes J., Naiem M., Mason D. Y., Stein H. Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology 1982; 45: 645–53
   PubMed Web of Science ®Google Scholar
• Hogg N., Ross G., Jones D. B., Slusarenko M., Walport M., Lachmann P. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). European Journal of Immunology 1984; 14: 236–243
   PubMed Web of Science ®Google Scholar
• Malavasi F., Funaro A., Bellone G., Calligaris Cappio F., Berti E., Tetta C., Dellabona P., de Maria S., Campogrande M., Cappa A. Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity. Journal of Clinical Immunology 1985; 5: 412–20
   PubMed Web of Science ®Google Scholar
• Weiss L., Delfraissy J., Vazquez A., Wallon C., Galanaud P., Kazatchkine M. D. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B-cell differentiation. The Journal of Immunology 1987; 138: 2988–93
   PubMed Web of Science ®Google Scholar
• Yoon S. H., Fearon D. T. Characterization of soluble form of the C3b/C4b receptor (CR1) in human plasma. Journal of Immunology 1985; 134: 3332
   PubMed Web of Science ®Google Scholar
• Weisman H. F., Bartow T., Leppo M., Marsh H., Carson G., Councino M., Bayle M., Roux K., Weisfeldt M., Fearon D. Soluble human complement receptor type 1: in vivo inhibitor or complement suppressing post-ischemia myocardial inflammation and necrosis. Science 1990; 249: 146–51
   PubMed Web of Science ®Google Scholar
• Inada Y. Hematologic correlates and the role of erythrocyte CR1 in the development of AIDS. AIDS Research 1986; 2: 235
   PubMedGoogle Scholar
• Tausk F. A., McCutchon A., Spechko P., Schereiber R., Gigli I. Altered erythrocyte C3b receptor expression, immuno complexes and complement activation in homosexual men in varying risk groups for acquire immunodeficiency syndrome. Journal of Clinical Investigation 1986; 78: 977–82
   PubMed Web of Science ®Google Scholar
• Tausk F., Hoffman T., Shreiber R., Gigli I. Leprosy: altered complement receptors in disseminated disease. Journal of Investigative Dermatology 1985; 85: 58S–61S
   PubMed Web of Science ®Google Scholar
• Schlesinger L. S., Horwitz M. A. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. Journal of Clinical Investigation 1990; 85: 1304–14
   PubMed Web of Science ®Google Scholar
• Kawaguchi T. Complement receptor 1 (CR1) on erythrocytes of patients with systemic lupus erythematosis. Japanese Journal of Human Genetics 1988; 33: 451
   Google Scholar
• Tebib J. G., Martinez C., Granados J., Alarcon-Segovia D., Schur P. H. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus. Arthritis and Reumatism 1989; 32: 1465–9
   PubMed Web of Science ®Google Scholar
• Gatnby P. A., Barbosa J. E., Lachman P. J. Differences between C4a and C4b in the handling of immune-complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clinical of Experimental Immunology 1990; 79: 158–63
   PubMed Web of Science ®Google Scholar
• Davies K. A., Hird V., Stewart S., Sivolapenko G. B., Jose P., Epenetos A. A., Walport M. J. A study of in vivo immunocomplex formation and clearance in man. Journal of Immunology 1990; 144: 4613–20
   PubMed Web of Science ®Google Scholar
• Currie M. S., Vala M., Pisetsky D. S., Greenberg C. S., Crawford J., Cohen J. Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood 1990; 15: 1699–704
   Google Scholar
• Cosio F. G., Shen X. P., Hebert L. A. Immunocomplexes bind preferentially to specific subpopulations of human erythrocytes. Clinical Immunology and Immuno-pathology 1990; 55: 337–54
   PubMedGoogle Scholar
• Lutz H. U. Erythrocyte clearance. Blood Cell Biochemistry, J. R. Harris. Plenum Press, New York and London 1990; vol 1: 81–120
   Google Scholar
• Itoh Y., Fukunaga Y., Yamamoto M. Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. II. E-CR1 levels in patients with various diseases and their correlation with B-CR1. Arerugi 1989; 38: 1276–87
   PubMedGoogle Scholar
• Yen J. H., Liu H. W., Lin S. F., Chen T. P. Erythrocyte complement receptor type 1 in patients with hematologic diseases. Chung Chinese 1989; 22: 186–92
   Google Scholar
• Morgan P., Walport M. Complement deficiency and disease. Immunology Today 1991; 12: 301–6
   PubMedGoogle Scholar
• Babcock G. F., Alexander J. W., Warden G. D. Flow cytometric analysis of neutrophil subsets in thermally injured patients developing infection. Clinical Immunology Immunopathology 1990; 54: 117–25
   PubMedGoogle Scholar
• Larcher C., Schultz T. F., Hofbauer J., Hengster P., Romani N., Wachter H., Dierich M. P. Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-infection of myeloid, T., and B cells. Journal of Acquired Immunodeficiency Syndrome 1990; 3: 103–8
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjian H. M., McCredie K., Trujillo J. M., Keatting M. J., Gutterman J. U. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. The New England Journal of Medicine 1986; 314: 1065–9
   PubMed Web of Science ®Google Scholar
• Hughes T., Morgan G., Matriat P., Goldman J. M. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874–8
   PubMed Web of Science ®Google Scholar
• Goldman J. M. Options for the management of chronic myeloid leukemia. Leukemia and Lymphoma 1990; 3: 159–64
   PubMed Web of Science ®Google Scholar
• Hayhoe F., Quaglino D. Cytochemical demonstration and measurement of leukocyte alkaline phosphatase activity in normal and pathological states. British Journal of Haematology 1958; 4: 375
   PubMed Web of Science ®Google Scholar
• Lanza F., Fietta A., Spisani S., Castoldi G. L., Traniello S. Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasm?. Journal of Clinical and Laboratory Immunology 1987; 22: 175–80
   PubMedGoogle Scholar
• Lanza F., Giuliani A. L., Amelotti F., Spisani S., Traniello S., Castoldi G. L. Depressed neutrophil-mediated tumour cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia. Haemato-logica 1988; 73: 355–8
   PubMed Web of Science ®Google Scholar
• Lanza F., Latorraca A., Musto P., Ferrari L., Moretti S., Zabucchi G., Carotenuto M., Castoldi G. L. Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency shows a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study. Annals of Hematology 1991; 63: 94–100
   PubMed Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber Ghosh W. N.A. K., Abdulaziz Z., MacDonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). The Journal of Histochemistry and Cytochemistry 1984; 32: 219–29
   PubMed Web of Science ®Google Scholar
• Tura S., Baccarani M., Corbelli G., The Italian Cooperative Study Group on Chronic Myeloid eukemia L. Staging of chronic myeloid leukemia. British Journal of Haematology 1981; 47: 105–11
   PubMed Web of Science ®Google Scholar
• Sokal J. E., Cox E. G., Baccarani M., Tura S., Gomez G. A., Robertson J. E., Tso C. Y., Braun T. J., Clarkson B. D., Cervantes F., Rozman C., Italian Cooperative C ML, Study Group. Prognostic discrimination in “good-risk” chronic granulocytic leukaemia. Blood 1984; 63: 789–99
   PubMed Web of Science ®Google Scholar
• Smith J. B., Campbell D. E., Ludomirsky A., Polin R. A., Douglas S. D., Garty B. Z. Expression of the complement receptors CR1 and CR3 and the type HI Fc gamma receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatric Research 1990; 28: 120–6
   PubMed Web of Science ®Google Scholar
• Spisani S., Gavioli R., Giuliani A. L., Traniello S. Triggering of neutrophils cytotoxicity against an antibody-coated tumor target by TPA. Immunology and Cell Biology 1989; 67: 385–9
   PubMed Web of Science ®Google Scholar
• Spisani S., Gavioli R., Chiozzi P., Lanza F., Bortolotti F., Traniello S. Lymphocytes treated with natural alfa-interferon produce a chemotactic factor for human neutrophils. Cell Biology International Reports 1989; 13: 163–9
   PubMedGoogle Scholar
• Miller J. B., McCarthy J. B., McGlave P. Neural cell adhesion molecule (N-CAM) is expressed on the surface of human myeloid cells from chronic myelogenous leukemia (CML) patients. Blood 1991; 78: 29a, abstract
   Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukemia. Nature 1987; 328: 342–44
   PubMed Web of Science ®Google Scholar
• Galvani D. W., Cawley J. C. Mechanism of action of a interferon in chronic granulocytic leukemia: evidence for preferential inhibition of late progenitors. British Journal of Haematology 1989; 73: 475–9
   PubMed Web of Science ®Google Scholar
• Santucci M. A., Butturini A., Gale R. P. Can long term bone marrow culture eliminate leukemic cells?. Leukemia and Lymphoma 1990; 3: 87–91
   PubMed Web of Science ®Google Scholar
• Dowding Guo C. A., Osterholz J., Siczkowsky M., Goldman J., Gordon M. Interferon-a overrides the deficient adhesion of chronic myeloid leukemia primitive progenitors cells to bone marrow stromal cells. Blood 1991; 78: 499–505
   PubMed Web of Science ®Google Scholar
• Osterholz J., Dowding C., Guo A. P., Siczkowsky M., Goldman J. M. Interferon a alters the distribution of CFU-GM between the adherent and non adherent compartments in long term cultures of chronic myeloid leukemia marrow. Experimental Hematology 1991; 19: 326–31
   PubMed Web of Science ®Google Scholar